• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Pfizer’s Bourla confident in company’s obesity drug position, despite delays

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 01, 2024 at 11:42: AM
via Pfizer missed its first chance at following Novo Nordisk and Eli Lilly into the fast-growing market for GLP-1 obesity drugs. CEO Albert Bourla is advising investors not to count it out too quickly the second time.

article source
 




Top Bottom
Back
Quote